Texas Bank & Trust Co Takes $3.67 Million Position in Oracle Co. (NYSE:ORCL)

Texas Bank & Trust Co acquired a new stake in shares of Oracle Co. (NYSE:ORCL) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 22,026 shares of the enterprise software provider’s stock, valued at approximately $3,670,000. Oracle accounts for 1.5% of Texas Bank & Trust Co’s investment portfolio, making the stock its 12th largest position.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Tidal Investments LLC boosted its stake in Oracle by 132.7% in the 4th quarter. Tidal Investments LLC now owns 384,283 shares of the enterprise software provider’s stock valued at $64,037,000 after buying an additional 219,115 shares in the last quarter. Tolleson Wealth Management Inc. acquired a new stake in Oracle in the 4th quarter valued at $451,000. True Wealth Design LLC boosted its stake in Oracle by 59.2% in the 4th quarter. True Wealth Design LLC now owns 788 shares of the enterprise software provider’s stock valued at $131,000 after buying an additional 293 shares in the last quarter. State of Wyoming boosted its stake in Oracle by 406.1% in the 4th quarter. State of Wyoming now owns 6,832 shares of the enterprise software provider’s stock valued at $1,138,000 after buying an additional 5,482 shares in the last quarter. Finally, Stonebrook Private Inc. boosted its stake in Oracle by 27.0% in the fourth quarter. Stonebrook Private Inc. now owns 4,098 shares of the enterprise software provider’s stock worth $683,000 after purchasing an additional 871 shares in the last quarter. 42.44% of the stock is currently owned by institutional investors.

Oracle Stock Up 0.6%

Shares of Oracle stock opened at $160.31 on Friday. Oracle Co. has a 1 year low of $114.55 and a 1 year high of $198.31. The business has a 50-day moving average of $142.91 and a two-hundred day moving average of $162.49. The company has a market capitalization of $448.39 billion, a P/E ratio of 39.20, a price-to-earnings-growth ratio of 3.46 and a beta of 1.27. The company has a debt-to-equity ratio of 5.65, a current ratio of 0.81 and a quick ratio of 0.81.

Oracle (NYSE:ORCL) last announced its quarterly earnings results on Monday, March 10th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.49 by ($0.02). Oracle had a return on equity of 133.25% and a net margin of 21.16%. The business had revenue of $14.13 billion during the quarter, compared to the consensus estimate of $14.40 billion. During the same quarter last year, the company earned $1.41 earnings per share. The firm’s revenue was up 6.4% compared to the same quarter last year. As a group, equities analysts predict that Oracle Co. will post 5 EPS for the current year.

Oracle Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 23rd. Investors of record on Thursday, April 10th were issued a dividend of $0.50 per share. The ex-dividend date was Thursday, April 10th. This is an increase from Oracle’s previous quarterly dividend of $0.40. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.25%. Oracle’s dividend payout ratio (DPR) is presently 46.95%.

Analyst Ratings Changes

A number of equities analysts have commented on ORCL shares. Royal Bank of Canada set a $145.00 price objective on Oracle and gave the stock a “sector perform” rating in a research note on Tuesday, March 11th. UBS Group reissued a “market perform” rating on shares of Oracle in a research note on Tuesday, March 11th. DA Davidson reduced their price objective on Oracle from $150.00 to $140.00 and set a “neutral” rating on the stock in a research note on Monday, April 14th. BMO Capital Markets reduced their price objective on Oracle from $205.00 to $175.00 and set a “market perform” rating on the stock in a research note on Tuesday, March 11th. Finally, Citigroup reduced their price objective on Oracle from $194.00 to $160.00 and set a “neutral” rating on the stock in a research note on Wednesday, March 12th. Fourteen equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $174.42.

Insider Buying and Selling

In related news, Director Leon E. Panetta sold 5,000 shares of the stock in a transaction dated Friday, April 11th. The stock was sold at an average price of $129.77, for a total transaction of $648,850.00. Following the completion of the transaction, the director now directly owns 58,090 shares in the company, valued at approximately $7,538,339.30. This trade represents a 7.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Naomi O. Seligman sold 2,866 shares of the stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $149.53, for a total value of $428,552.98. Following the transaction, the director now owns 31,764 shares of the company’s stock, valued at approximately $4,749,670.92. The trade was a 8.28% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 27,366 shares of company stock worth $4,015,723. 42.20% of the stock is owned by corporate insiders.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.